In CCR2 deficient DCIS.com cells, HTRA2 knockdown did not restore cellular invasion, suggesting that CCR2 deficiency inhibits expression or activity of other components required for cellular invasion such as TWIST1. This evidence concerns the gene HTRA2 and ductal breast carcinoma in situ.